Maximum quantity allowed is 999
CAS RN: 127-07-1 | Product Number: H0310
Hydroxyurea
Purity: >97.0%(HPLC)(N)
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
$40.00
|
14 | ≥100 | Contact Us | |
| 25G |
$110.00
|
13 | ≥100 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | H0310 |
Purity / Analysis Method
|
>97.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | CH__4N__2O__2 = 76.06 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic |
| CAS RN | 127-07-1 |
| Reaxys Registry Number | 1741548 |
| PubChem Substance ID | 87570732 |
| SDBS (AIST Spectral DB) | 3920 |
| Merck Index (14) | 4848 |
| MDL Number | MFCD00007943 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| NMR | confirm to structure |
| Melting Point | 140 °C |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. H340 : May cause genetic defects. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
| RTECS# | YT4900000 |
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2928.00-000 |
References
- 1) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
References
- Mechanism of action of hydroxyurea (a review)
- Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide
- Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication
- Pharmacokinetics and pharmacodynamics of hydroxyurea (a review)
- Nitric oxide production from hydroxyurea (a review)
- Colorimetric determination of hydroxyurea in human serum using high-performance liquid chromatography
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.